- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Global Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
UPDATED Jan 26, 2023
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VRTXVertex Pharmaceuticals | US$321.02 | 3.6% | 32.1% | US$82.4b | US$328.17 | PE25.2x | E9.0% | n/a | ||
| MRNAModerna | US$193.24 | -0.4% | 21.2% | US$74.2b | US$228.88 | PE6.3x | E-10.7% | n/a | ||
| VIRVir Biotechnology | US$29.99 | 8.7% | -11.7% | US$4.0b | US$50.75 | PE3.5x | E-33.0% | n/a | ||
| ABCLAbCellera Biologics | US$10.52 | 1.7% | 22.5% | US$3.0b | US$29.10 | PE12.1x | E-41.7% | n/a | ||
| RSCFReflect Scientific | US$0.06 | -4.8% | -53.7% | US$5.1m | n/a | PE10x | n/a | n/a |
Page 1 of 1